Newark Beth Israel Medical Center’s Metabolic and Bariatric Surgery program has been accredited as a Comprehensive Center by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP®), a joint Quality Program of the American College of Surgeons (ACS) and the American Society for Metabolic and Bariatric Surgery (ASMBS).
According to hospital officials, this accreditation recognizes Newark Beth Israel Medical Center’s Metabolic and Bariatric Surgery Program for meeting the highest patient safety and quality standards in the greater New Jersey and metropolitan New York area.
The program meets national criteria for staffing, training, facility infrastructure and patient care pathways to support the delivery of high-quality, safe care for patients with obesity.
“Metabolic and bariatric surgery patients require a unique level of support throughout their weight-loss journey, from pre-operative treatments to long-term follow-up care post-surgery. I am very proud of the work that our multidisciplinary team of clinicians, social workers, and nutritionists are doing to deliver this high level of care,” said Alan A. Saber, MD, MS, FACS, FASMBS, ABOM, Bariatric and Metabolic Surgery Program Director at Newark Beth Israel Medical Center.
“In just four years, Dr. Saber has built an exceptional Metabolic and Bariatric surgery program at Newark Beth Israel Medical Center.
His team is delivering excellent, safe care to our patients. This accreditation is a testament to their dedication, said Darrell K. Terry, Sr., MHA, MPH, FACHE, President and Chief Executive Officer, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey.
The MBSAQIP Standards, Optimal Resources for Metabolic and Bariatric Surgery, ensures that metabolic and bariatric patients receive multidisciplinary medical care, which improves patient outcomes and long-term success. MBSAQIP-Accredited centers offer preoperative and postoperative care designed specifically for patients with obesity.
The Centers for Disease Control and Prevention (CDC) estimates about 93 million adults in the United States are affected by obesity and that number continues to increase.
The disease of obesity increases the risks of morbidity and mortality because of the diseases and conditions that are commonly associated with it, such as type II diabetes, hypertension, cardiovascular disease, and cancer, among other health risks.
Metabolic and bariatric surgery has proven to be effective in the reduction of comorbid conditions related to obesity.